![Frèdèrique Menzaghi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frèdèrique Menzaghi
Plus aucun poste en cours
Profil
Frèdèrique Menzaghi is the founder of CARA Therapeutics, Inc. founded in 2004, where she held the title of Chief Scientific Officer and Senior VP-R&D until 2024.
She is also the founder of Sibia Neurosciences, Inc. Dr. Menzaghi's former jobs include Director-In Vivo Pharmacology at Arena Pharmaceuticals, Inc. from 1999 to 2003, Principal at Eli Lilly & Co., and Vice President-Pharmacology & Business Development at Psychogenics, Inc. from 2003 to 2004.
Dr. Menzaghi received a doctorate from the University of Strasbourg and a graduate degree from Ecole des Mines de Nancy.
Anciens postes connus de Frèdèrique Menzaghi
| Sociétés | Poste | Fin |
|---|---|---|
| CARA THERAPEUTICS, INC. | Fondateur | 02/02/2024 |
Psychogenics, Inc.
 Psychogenics, Inc. BiotechnologyHealth Technology Operates as a preclinical CRO that develops therapeutics for CNS and orphan disorders | Corporate Officer/Principal | 01/01/2004 |
| ARENA PHARMACEUTICALS | Corporate Officer/Principal | 01/01/2003 |
Sibia Neurosciences, Inc.
 Sibia Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule therapeutics for disorders of the nervous system | Fondateur | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Formation de Frèdèrique Menzaghi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
35
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Sibia Neurosciences, Inc.
Sibia Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, small molecule therapeutics for disorders of the nervous system | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
CARA Therapeutics, Inc.
 CARA Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes new chemical entities designed to fundamentally change the way acute pain, chronic pain and pruritus are managed | Health Technology |
University of Strasbourg
 University of Strasbourg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ecole des Mines de Nancy
 Ecole des Mines de Nancy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Psychogenics, Inc.
Psychogenics, Inc. BiotechnologyHealth Technology Operates as a preclinical CRO that develops therapeutics for CNS and orphan disorders | Health Technology |
